OMERS Administration Corp’s Inozyme Pharma INZY Stock Holding History

OMERS Administration Corp’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,116,800	Closed	-$4.47M	–	1178
2025 Q2	$4.47M	Buy	+1,116,800	New	+$2.77M	0.04%	181

OMERS Administration Corp's INZY Position: Q3 2025 in Review

OMERS Administration Corp sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,116,800 shares — an estimated $4.47M sold.

OMERS Administration Corp first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $4.47M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

OMERS Administration Corp reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
OMERS Administration Corp sold 1,116,800 Inozyme Pharma shares in Q3 2025, an estimated $4.47M.
OMERS Administration Corp first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
OMERS Administration Corp's Inozyme Pharma position peaked at $4.47M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on OMERS Administration Corp's 13F filing for Q3 2025, filed 14 Nov 2025.